Isolated hepatic perfusion is effective therapy for unresectable, isolated liver metastases

被引：0
|
作者：
D'Alessio, M. J.
Anunobi, R.
Gamblin, T. C.
Holtzman, M.
Pappas, S.
Brown, C. K.
Zeh, H. J.
Bartlett, D. L.
机构：
[1] Univ S Alabama, Mitchell Canc Inst, Mobile, AL 36688 USA
[2] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2007年 / 14卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：105 / 105
页数：1
相关论文
共 50 条
  • [41] EXTRACORPOREAL HEPATIC PERFUSION WITH ISOLATED DOG LIVER
    ORTIZHUR.H
    TEIJEIRA, J
    GOITI, J
    GONZALEZ, L
    VOLTAS, J
    DURAN, CMG
    [J]. REVISTA ESPANOLA DE FISIOLOGIA, 1973, 29 (01): : 27 - 31
  • [42] Hyperthermic Isolated Liver Perfusion for Unresectable Liver Cancers: Pilot Study
    Lise, M.
    Pilati, P.
    da Pian, P.
    Mocellin, S.
    Ori, C.
    Casara, D.
    Rossi, C. R.
    Darisi, T.
    Corazzina, S.
    Nitti, D.
    [J]. JOURNAL OF CHEMOTHERAPY, 2004, 16 : 37 - 39
  • [43] A Phase I Trial of Isolated Hepatic Perfusion (IHP) using 5-FU and Oxaliplatin in Patients with Unresectable Isolated Liver Metastases (ILM) from Colorectal Cancer (CRC)
    Magge, D.
    Zureikat, A.
    Bartlett, D.
    Holtzman, M.
    Choudry, H.
    Beumer, J.
    Holleran, J. L.
    Strychor, S.
    Pingpank, J.
    Zeh, H. J.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S115 - S115
  • [44] A phase I trial of isolated hepatic perfusion (IHP) using 5-FU and oxaliplatin in patients with unresectable isolated liver metastases (ILM) from colorectal cancer (CRC)
    Magge, Deepa
    Zureikat, Amer H.
    Bartlett, David L.
    Holtzman, Matthew Peter
    Choudry, Haroon
    Beumer, Jan H.
    Holleran, Julianne L.
    Strychor, S.
    Pingpank, James F.
    Zeh, Herbert
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [45] A bi-modality treatment of hepatic arterial therapy (HAT) of unresectable isolated colorectal liver metastases (CLM). Our experience
    Jafelice, G
    Pittureri, C
    Mazziotti, A
    Jovine, E
    Grazi, GL
    Golfieri, R
    Giampalma, M
    Piccinini, E
    Di Stefano, A
    Piana, E
    Martoni, A
    Pannuti, F
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 : S78 - S79
  • [46] Are there indications for intraarterial hepatic chemotherapy or isolated liver perfusion? The case of liver metastases from colorectal cancer
    Rougier, P
    [J]. ISOLATED LIVER PERFUSION FOR HEPATIC TUMORS, 1998, 147 : 3 - 12
  • [47] Current role of hepatic artery infusion and isolated liver perfusion for the treatment of colorectal cancer liver metastases
    Elaraj, DM
    Alexander, HR
    [J]. CANCER JOURNAL, 2004, 10 (02): : 128 - 138
  • [48] Chemosaturation With Percutaneous Hepatic Perfusion in Unresectable Hepatic Metastases
    Glazer, Evan S.
    Zager, Jonathan S.
    [J]. CANCER CONTROL, 2017, 24 (01) : 96 - 101
  • [49] Analysis of factors associated with outcome in patients undergoing isolated hepatic perfusion (IHP) for unresectable liver metastases (LM) from colorectal cancer (CRC)
    Alexander, H.
    Pingpank, J. F.
    Libutti, S. K.
    Bartlett, D. L.
    Fraker, D. L.
    Royal, R. E.
    Steinberg, S. M.
    Beresnev, T. H.
    Helsabeck, C. B.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (02) : 5 - 6
  • [50] Isolated Pelvic Perfusion as Neoadjuvant Therapy for Advanced/Unresectable Malignancy
    Wanebo, H.
    Belliveau, J.
    Gustafson, E.
    DiSienna, M.
    Begossi, G.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2010, 17 : S79 - S79
12345